NFKB1 and metabolic syndrome: These findings suggested that BUDE has the potential to block the activation of NF-κB signaling pathway to mitigate liver and pancreatic inflammation and minimize the harm caused by “overindulge in fatty, sweet and thick flavors” in rats with MetS.